Accelerated approvals, surrogate end points, and high drug costs are reshaping cancer center formulary decisions, explained panelists at PCOC.
|Articles|June 20, 2017
Supplements and Featured Publications
- Atopic Dermatitis: Focusing on the Patient Care Strategy in the Managed Care Setting
- Volume 23
- Issue 8
Atopic Dermatitis: Focusing on the Patient Care Strategy in the Managed Care Setting
Advertisement
Release date: June 2017
Expiration date: June 2018
Pharmacy Credit
Instructions for Receiving Continuing Pharmacy Education (CPE) Credit: Testing and Grading Information
This lesson is free online; receive instant grading and request your CE credit at www.PharmacyTimes.org.
Testing and Grading Directions
Participants evaluating the activity and achieving a passing grade of 70% or higher on the online posttest are eligible to receive CE credit.
Articles in this issue
over 9 years ago
Participating Facultyover 9 years ago
Treatment and Managed Care Issues of Atopic Dermatitisover 9 years ago
Overview of Atopic DermatitisAdvertisement
Related to this article
Most community oncology practices now administer bispecific antibodies in-office, but reimbursement gaps remain a top barrier, a survey finds.
Tammy Lundstrom, MD, JD, discusses the new childhood vaccine order, single-dose MMR access concerns, and the measles resurgence.
Switching MS patients to subcutaneous ocrelizumab cut chair time 82.8% and delivered $514,544 in 3-year value, a UVA analysis finds.
Topical ruxolitinib prescribing in Medicare Part D surged through 2024, but its cost per day runs 16 times higher than generic tacrolimus.
Baseline biopsies separated 16 patients who later developed hepatocellular carcinoma from 32 matched controls a median 6.1 years ahead.
A narrative review finds specialty pharmacies lack a patient-reported outcome measure built for their workflow, despite frequent contact with patients with MS.
Patients with colorectal or ovarian cancer enrolled in a clinical trial have lower pharmacy and medical costs during the 9 months after trial initiation.
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD
2
Nearly a Decade After CAR T, Medicare’s Cell and Gene Therapy Payment Gap Persists
3
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
4
Twice-Daily Deuruxolitinib Outperformes Once-Daily in Severe AA
5